Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03417024 · ClinicalTrials.gov registry record
Automated Breast Ultrasound Case Collection Registry
A clinical trial, sponsored by GE Healthcare.
- Terminated
- Registry status
- 13
- Enrollment target
NCT03417024: Clinical Trial study, sponsored by GE Healthcare.
NCT03417024 is a clinical trial that was terminated before completion, run by GE Healthcare. The registered enrollment target is 13 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03417024 was terminated before completion, sponsored by GE Healthcare.
- TERMINATED
- Registry status
- 13 participants
- Enrollment target
Study Summary
The contribution of automated breast ultrasound (ABUS) to the screening pathway for breast cancer is not fully understood. This prospective study aims to collect longitudinal data in women with dense breasts undergoing ABUS as a supplement to digital breast tomosynthesis (DBT). The data are intended for use in future research on the value and effectiveness of ABUS in routine clinical care. Data will be collected from eligible women who have been prescribed or have completed DBT and ABUS, screening within a 30-day window. Radiologist evaluations and, when performed, outcomes of biopsy and/or laboratory testing will be recorded. Subjects will be followed for breast cancer status and results of any diagnostic breast exams and/or treatment.
Interventions
- DEVICE Digital Breast Tomosynthesis
- DEVICE Automated Breast Ultrasound
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 13 participants |
| Start Date | 2018-07-12 |
| Est. Completion | 2019-01-25 |
Why NCT03417024 stopped before completion
NCT03417024 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 13 participants, a relatively small participant target.
The record links to 0 conditions, and to 2 interventions - of which Digital Breast Tomosynthesis is the first listed.
NCT03417024 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03417024 about?
NCT03417024 is a clinical study titled "Automated Breast Ultrasound Case Collection Registry". The contribution of automated breast ultrasound (ABUS) to the screening pathway for breast cancer is not fully understood. This prospective study aims to collect longitudinal data in women with dense breasts undergoing ABUS as a supplement to digital breast tomosynthesis (DBT). The data are intended...
What is the current status of trial NCT03417024?
This trial is currently terminated. The enrollment target is 13 participants. The study started on 2018-07-12. Estimated completion is 2019-01-25.
What interventions are being tested in trial NCT03417024?
The interventions under investigation include: Digital Breast Tomosynthesis (DEVICE), Automated Breast Ultrasound (DEVICE).
Who is sponsoring clinical trial NCT03417024?
This trial is sponsored by GE Healthcare, which has 99 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03125655 · 13 participants
Regulation of Inflammatory Genes in Psoriasis
- NCT03774446 · 13 participants · Phase 2
Multicenter Study of Seliciclib (R-roscovitine) for Cushing Disease
- NCT03830151 · 13 participants · Phase 1
Hyperpolarized Carbon C 13 Pyruvate in Diagnosing Glioma in Patients With Brain Tumors
- NCT04573231 · 13 participants · Phase 2
Evaluation of PSMA in HER2- AR+ Metastatic Breast Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI